Oppenheimer reiterates Outperform on Connect Biopharma; $5 target
Oppenheimer maintained an Outperform rating on Connect Biopharma and kept a $5.00 price target, implying 278.8% upside versus a Sep 21 close of $1.32.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.